⌘K
Paras Healthcare Limited is one of the largest healthcare providers in North India, Bihar, and Jharkhand, focusing on tertiary and quaternary care. The company operates a network of hospitals with a well-recognized brand and a first-mover advantage in its target regions.
The company demonstrates strong business quality, growth potential, and positive market sentiment, supported by a recent financial turnaround and a relatively fair post-IPO P/E compared to peers. However, significant concerns regarding high debt, low capital efficiency (ROCE), and critical governance/litigation risks necessitate a cautious approach.
Strong GMP (16.59% premium), quality anchor investor participation, and relatively fair post-IPO valuation compared to peers suggest good listing prospects.
Positive market sentiment and recent financial turnaround could drive short-term gains, but high debt and governance risks warrant caution.
Strong market position in a growing healthcare sector and clear growth strategies offer long-term potential. However, high debt and governance issues need careful monitoring for sustained value creation.
Listing-day performance is not available yet. It will appear here once this IPO has listed and results are recorded.
| Category | Shares Offered | % of Issue | Share |
|---|---|---|---|
| QIB | — | 75% | |
| Retail | — | 10% | |
| NII | — | 15% |
Grey-market premium history is not yet available for this issue.
Premium gain of 16.59% over issue price.
Subscription opens on 21 Oct. Live demand will appear here.
One of the largest healthcare providers in North India, Bihar, and Jharkhand with a first-mover advantage and a well-recognized brand.
Strong focus on tertiary and quaternary care with high contribution from CONGOR specialties.
Consistent revenue growth with a CAGR of 19.08% (FY24-FY26).
Recent turnaround to profitability in FY26 and Q1FY27 with healthy EBITDA and PAT margins.
Positive and growing operating cash flows.
Strong institutional anchor investor participation (39 investors including SBI, HDFC, Blackrock, ADIA).
Attractive post-IPO P/E of 37.72x compared to industry average and peers.
Successful execution of expansion plans, improved operational efficiencies, effective debt reduction, and sustained demand for tertiary/quaternary care.
Continued revenue growth in line with historical trends, gradual improvement in profitability, and stable regulatory environment.
Failure to manage high debt, increased regulatory scrutiny, intense competition, and inability to scale operations effectively leading to margin pressure or return to losses.
Positive: Strong revenue growth (19.08% CAGR FY24-FY26).
Red flag: high leverage (D/E 3.21) -> -12.0 pts on fundamentals
Listing-gain vs long-term: Neutral / Avoid.
Concern: High debt-to-equity ratio (3.21).